Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
5.91
-0.33 (-5.29%)
At close: Sep 2, 2025, 4:00 PM
5.91
+0.01 (0.17%)
Pre-market: Sep 3, 2025, 6:12 AM EDT
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $216.51 million as of September 3, 2025. Its market cap has decreased by -22.70% in one year.
Market Cap
216.51M
Enterprise Value
192.51M
1-Year Change
-22.70%
Ranking
Category
Stock Price
$5.91
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $216.51M, a decrease of -57.22%. That is a compound annual growth rate of -16.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 216.51M | -32.35% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |